In detail, endothelial lipase (EL; LIPG) plays a key role in atherosclerosis, and is actively investigated as a modulator in inflammatory processes and cancer [30,31], with examples of inhibitors of natural origin targeting closely related triacyglycerol lipases [32,33]. Here, LIPG is linked to atherosclerosis.